New shot aims to stop dangerous infection risk in cancer patients
NCT ID NCT07434063
First seen Feb 26, 2026 · Last updated May 08, 2026 · Updated 11 times
Summary
This study looks at whether a medicine called mecapegfilgrastim can help prevent neutropenia (dangerously low white blood cells) in cancer patients after chemotherapy, radiation, or immunotherapy. About 200 adults with solid tumors will receive the injection to see if it reduces fevers and severe infections. The goal is to make cancer treatment safer and keep patients healthier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUTROPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HebeiMuFH
RECRUITINGShijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.